Legionnaires' discovery prompts GlaxoSmithKline to idle NC plant

After detecting the bacteria for Legionnaires' disease in a cooling tower, GlaxoSmithKline ($GSK) temporarily closed a manufacturing site in North Carolina. GSK sent employees home while it cleans the tower and investigates. The discovery comes as an outbreak of the infection has resulted in a dozen deaths in New York. More from FiercePharma

Suggested Articles

After showing Nucala could cut the rates of flares for hypereosinophilic syndrome, GSK is planning regulatory filings in 2020.

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Both IL-17A inhibitors have rolled out data showing they work in non-radiographic axial spondyloarthritis.